Effect of Addition of Aromatase Inhibitor to Ovarian Stimulation Therapy in IVF Treatment

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

129

Participants

Timeline

Start Date

February 1, 2017

Primary Completion Date

October 30, 2018

Study Completion Date

October 30, 2018

Conditions
Infertility
Interventions
DRUG

Letrozole

Adjuvant therapy to recFSH during ovarian stimulation

DRUG

Placebo

Adjuvant therapy to recFSH during ovarian stimulation

Trial Locations (4)

2100

Department of Fertility, Juliane Marie Centeret, Copenhagen

2650

Clinic of Fertility, Hvidovre Hospital, Hvidovre

2730

Unit of Reproductive Medicine, Herlev Hospital, Herlev

4300

Clinic of Fertility, Holbæk Hospital, Holbæk

All Listed Sponsors
collaborator

Rigshospitalet, Denmark

OTHER

collaborator

Hvidovre University Hospital

OTHER

collaborator

Holbaek Sygehus

OTHER

collaborator

Region Capital Denmark

OTHER

collaborator

Copenhagen University Hospital, Denmark

OTHER

collaborator

Zealand University Hospital

OTHER

lead

Sven O. Skouby

OTHER

NCT02946684 - Effect of Addition of Aromatase Inhibitor to Ovarian Stimulation Therapy in IVF Treatment | Biotech Hunter | Biotech Hunter